Rachel Grashow, PhD, MS; Marc G. Weisskopf, PhD, ScD; Karen K. Miller, MD; et al.
open access
has audio
JAMA Neurol. 2019;76(12):1428-1438. doi:10.1001/jamaneurol.2019.2664
This cross-sectional study examines the association between self-reported concussion symptoms at the time of US-style football injury and self-reported low testosterone levels and erectile dysfunction indicators in US former professional football players.
-
Podcast:
Association of Concussion Symptoms With Testosterone Levels and Erectile Dysfunction
-
Podcast:
Football Players and Erectile Dysfunction Associated With Repetitive Head Injury
Shelagh B. Coutts, MD; Francois Moreau, MD; Negar Asdaghi, MD; et al.
free access
has audio
JAMA Neurol. 2019;76(12):1439-1445. doi:10.1001/jamaneurol.2019.3063
This cohort study examines the frequency of acute infarction defined by diffusion restriction detected on magnetic resonance imaging scans among patients with low-risk, mild, or transient focal neurologic symptoms.
-
Podcast:
Rate and Prognosis of Brain Ischemia in Lower-Risk Transient or Persistent Minor Neurologic Events
Tim Sinnecker, MD; Margareta A. Clarke; Dominik Meier, PhD; et al.
free access
JAMA Neurol. 2019;76(12):1446-1456. doi:10.1001/jamaneurol.2019.2478
This cross-sectional European study evaluates the application of optimized magnetic resonance imaging protocols at 3 Tesla (T) for detecting and distinguishing MS from other conditions that mimic MS among adults.
José M. Ferro, MD, PhD; Jonathan M. Coutinho, MD, PhD; Francesco Dentali, MD; et al.
open access
JAMA Neurol. 2019;76(12):1457-1465. doi:10.1001/jamaneurol.2019.2764
This randomized clinical trial conducted in 9 countries compares the use of dabigatran with warfarin in stroke prevention among patients who just experienced cerebral venous thrombosis.
Yuesong Pan, PhD; Jordan J. Elm, PhD; Hao Li, PhD; et al.
free access
JAMA Neurol. 2019;76(12):1466-1473. doi:10.1001/jamaneurol.2019.2531
This pooled analysis combines data from 2 randomized clinical trials to estimate the efficacy and risk of dual antiplatelet therapy after minor ischemic stroke or transient ischemic attack.
Martina Absinta, MD, PhD; Pascal Sati, PhD; Federica Masuzzo, MD; et al.
free access
has multimedia
JAMA Neurol. 2019;76(12):1474-1483. doi:10.1001/jamaneurol.2019.2399
This cohort study examines association between chronic active lesions and clinical outcomes in US patients with multiple sclerosis.
-
Video:
Time-lapse Magnetic Resonance Imaging (MRI) From a Patient With Multiple Sclerosis (MS) and Expanding Rim Lesions Characterized Neuropathologically at Autopsy
-
Video:
Time-lapse Magnetic Resonance Imaging (MRI) From a Patient With Multiple Sclerosis (MS) Showing an Expanding Rim+ and a Shrinking Rim鈭� Lesion
Stefan A. Helwig; Andreas Ragoschke-Schumm, MD; Lenka Schwindling; et al.
free access
JAMA Neurol. 2019;76(12):1484-1492. doi:10.1001/jamaneurol.2019.2829
This randomized clinical trial explores how prehospital management optimized by the use of the Los Angeles Motor Scale compares with prehospital management in a mobile stroke unit that includes vascular imaging in accurately triaging patients with stroke to the appropriate target hospital providing (comprehensive stroke center) or not providing (primary stroke center) neurointerventional treatment.
David J. Gladstone, MD, PhD, FRCPC; Richard I. Aviv, MD; Andrew M. Demchuk, MD; et al.
free access
JAMA Neurol. 2019;76(12):1493-1501. doi:10.1001/jamaneurol.2019.2636
This randomized clinical trial investigates whether recombinant activated coagulation factor VII reduces hemorrhage expansion among patients with spot sign鈥損ositive intracerebral hemorrhage (ICH).